Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study
- PMID: 36479080
- PMCID: PMC9720309
- DOI: 10.3389/fonc.2022.918539
Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study
Abstract
Objectives: Detection of volatile organic compounds (VOCs) from bodily fluids with field asymmetric waveform ion mobility spectrometry (FAIMS) and related methods has been studied in various settings. Preliminary results suggest that it is possible to detect prostate, colorectal, ovarian and pancreatic cancer from urine samples. In this study, our primary aim was to differentiate pancreatic cancer from pancreatitis and benign tumours of the pancreas by using bile samples obtained during endoscopic retrograde cholangiopancreatography (ERCP). Secondarily, we aimed to differentiate all pancreatic region malignancies from all other kinds of benign causes of biliary obstruction.
Methods: A bile sample was successfully aspirated from 94 patients during ERCP in Tampere University Hospital. Hospital and patient records were prospectively followed up for at least two years after ERCP. Bile samples were analysed using a Lonestar chemical analyser (Owlstone, UK) using an ATLAS sampling system and a split-flow box. Diagnoses and corresponding data from the analyses were matched and divided into two subcategories for comparison. Statistical analysis was performed using linear discriminant analysis, support vector machines, and 5-fold cross-validation.
Results: Pancreatic cancers (n=8) were differentiated from benign pancreatic lesions (n=9) with a sensitivity of 100%, specificity of 77.8%, and correct rate of 88%. All pancreatic region cancers (n=19) were differentiated from all other kinds of benign causes of biliary obstruction (n=75) with corresponding values of 21.1%, 94.7%, and 80.7%. The sample size was too small to try to differentiate pancreatic cancers from adjacent cancers.
Conclusion: Analysing bile VOCs using FAIMS shows promising capability in detecting pancreatic cancer and other cancers in the pancreatic area.
Keywords: ERCP; FAIMS; VOC; bile; biliary obstruction; cholangiocarcinoma; pancreatic cancer; pancreatitis.
Copyright © 2022 Teränen, Nissinen, Roine, Antila, Siiki, Vaalavuo, Kumpulainen, Oksala and Laukkarinen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study.Gastrointest Endosc. 2014 Jul;80(1):97-104. doi: 10.1016/j.gie.2013.12.031. Epub 2014 Feb 19. Gastrointest Endosc. 2014. PMID: 24559784 Clinical Trial.
-
Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observation.Gastrointest Endosc. 2014 Dec;80(6):1038-45. doi: 10.1016/j.gie.2014.04.016. Epub 2014 Jun 11. Gastrointest Endosc. 2014. PMID: 24929484
-
Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis.Anticancer Res. 2019 Jan;39(1):73-79. doi: 10.21873/anticanres.13081. Anticancer Res. 2019. PMID: 30591442
-
Advances in the endoscopic management of patients with pancreatic and biliary malignancies.South Med J. 2006 Dec;99(12):1358-66. doi: 10.1097/01.smj.0000251324.81191.cd. South Med J. 2006. PMID: 17233192 Review.
-
Management of biliary and duodenal complications of chronic pancreatitis.World J Surg. 2003 Nov;27(11):1258-70. doi: 10.1007/s00268-003-7246-7. Epub 2003 Oct 13. World J Surg. 2003. PMID: 14534824 Review.
Cited by
-
Volatile Organic Compounds in Biological Matrices as a Sensitive Weapon in Cancer Diagnosis.Pharmaceuticals (Basel). 2025 Apr 27;18(5):638. doi: 10.3390/ph18050638. Pharmaceuticals (Basel). 2025. PMID: 40430459 Free PMC article. Review.
-
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers.Cancers (Basel). 2023 Apr 14;15(8):2308. doi: 10.3390/cancers15082308. Cancers (Basel). 2023. PMID: 37190235 Free PMC article. Review.
-
Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database.BMC Pharmacol Toxicol. 2025 Mar 19;26(1):65. doi: 10.1186/s40360-025-00884-5. BMC Pharmacol Toxicol. 2025. PMID: 40108669 Free PMC article.
-
The human volatilome meets cancer diagnostics: past, present, and future of noninvasive applications.Metabolomics. 2024 Oct 7;20(5):113. doi: 10.1007/s11306-024-02180-5. Metabolomics. 2024. PMID: 39375265 Review.
References
LinkOut - more resources
Full Text Sources